DIMENSIONAL FUND ADVISORS LP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 142 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,335,457
+124.6%
1,974,812
+64.8%
0.00%
+200.0%
Q2 2023$3,710,480
+99.0%
1,198,110
-10.7%
0.00%0.0%
Q1 2023$1,864,821
+76139.6%
1,341,803
+9.2%
0.00%0.0%
Q4 2022$2,446
-99.9%
1,229,168
-9.6%
0.00%0.0%
Q3 2022$2,748,000
-52.3%
1,360,021
-24.9%
0.00%
-50.0%
Q2 2022$5,756,000
-15.8%
1,809,792
+10.4%
0.00%0.0%
Q1 2022$6,836,000
-5.8%
1,639,322
+8.2%
0.00%0.0%
Q4 2021$7,258,000
+1.2%
1,515,021
+12.9%
0.00%0.0%
Q3 2021$7,170,000
+1.1%
1,342,392
-3.0%
0.00%0.0%
Q2 2021$7,089,000
+14.8%
1,384,433
+50.9%
0.00%0.0%
Q1 2021$6,176,000
+201.3%
917,707
+104.5%
0.00%
+100.0%
Q4 2020$2,050,000
+78.6%
448,648
+51.7%
0.00%
Q3 2020$1,148,000
+22.1%
295,816
+49.8%
0.00%
Q2 2020$940,000
+2373.7%
197,462
+1716.2%
0.00%
Q1 2020$38,000
-89.8%
10,872
-79.0%
0.00%
Q2 2019$372,000
-87.5%
51,841
-75.2%
0.00%
-100.0%
Q1 2019$2,967,000
-77.3%
209,421
-78.3%
0.00%
-83.3%
Q4 2018$13,042,000
-64.0%
963,802
-41.0%
0.01%
-57.1%
Q3 2018$36,274,000
-4.7%
1,634,752
-29.5%
0.01%
-6.7%
Q2 2018$38,076,0002,320,2880.02%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$103,087,0005.89%
Eversept Partners, LP 6,440,572$30,850,3401.97%
TPG GP A, LLC 16,213,367$77,662,0000.78%
Signature Wealth Management Partners, LLC 87,666$420,0000.36%
Hedges Asset Management LLC 75,000$359,0000.28%
Hillsdale Investment Management Inc. 869,916$4,167,0000.28%
Tranquilli Financial Advisor LLC 71,414$342,0000.24%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$862,0000.19%
GLOBEFLEX CAPITAL L P 297,414$1,424,0000.15%
XTX Topco Ltd 23,742$114,0000.06%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders